Regeneron Pharmaceuticals, Inc. (REGN)
698.25
-14.62
(-2.05%)
USD |
NASDAQ |
May 15, 16:00
621.52
-76.73
(-10.99%)
After-Hours: 06:28
Regeneron Pharmaceuticals Shareholders Equity (Quarterly) : 31.42B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| AbbVie, Inc. | -6.656B |
| Biogen, Inc. | 18.65B |
| Eli Lilly & Co. | 31.20B |
| Merck & Co., Inc. | 45.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.87B |
| Total Liabilities (Quarterly) | 9.445B |
| Debt to Equity Ratio | 0.0861 |
| Current Ratio | 3.565 |
| Net Debt Paydown Yield | 0.06% |